Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Neurons are quiescent cells that survive for several decades, many times the turnover time of most organelles and proteins, and so with advancing age neurons become affected by degenerative diseases. Autophagy is thought to be an important cellular mechanism preventing cell degeneration in such long-lived cells. We have recently found that the Parkinson disease (PD) gene leucine rich repeat kinase 2 (LRRK2) is directly involved in this process by acting as a negative regulator of autophagic activity. We created a novel genomic DNA reporter cellular model using a new recombineering strategy called Sequential insertion of Target with ovErlapping Primers (STEP) to express a genomic DNA locus YPet-LRRK2 fusion protein. Expression of the R1441C mutant form of LRRK2 induces a cellular phenotype of impaired autophagic balance at the convergent crossroads of the endocytic and autophagic avenues. Conversely, RNAi-induced knockdown of LRRK2 increases autophagic activity. Taken together, these data demonstrate the key role of LRRK2 in regulating autophagy and suggest modulation of LRRK2 function may represent a promising therapeutic target to help restore autophagic equilibrium in neurodegenerative diseases.

Original publication




Journal article



Publication Date





1208 - 1210


Autophagy, Endosomes, Humans, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Membrane Microdomains, Models, Biological, Parkinson Disease, Protein Serine-Threonine Kinases, RNA Interference